Issue 3/2016
Content (8 Articles)
Update on Metastatic Uveal Melanoma: Progress and Challenges
Francesco Spagnolo, Virginia Picasso, Laura Spano, Enrica Tanda, Clary Venzano, Paola Queirolo
Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors
Genevieve Evin
Assessing the Immunogenicity of Biopharmaceuticals
Carlos Pineda, Gilberto Castañeda Hernández, Ira A. Jacobs, Daniel F. Alvarez, Claudio Carini
Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
Xinlin Chen, Jiangtao Hou, Yujie Yuan, Chaoyuan Huang, Tianwen Liu, Chuanwei Mo, Haiwen Li, Bin Chen, Qian Xu, Zhengkun Hou, Weiling He, Fengbin Liu
Anagrelide and Mutational Status in Essential Thrombocythemia
Alessandra Iurlo, Daniele Cattaneo, Nicola Orofino, Cristina Bucelli, Sonia Fabris, Agostino Cortelezzi
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab
Hector A. Cuello, Valeria I. Segatori, Marina Alberto, Analía Pesce, Daniel F. Alonso, Mariano R. Gabri
Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets
Anna Hausberger, William C. Lamanna, Martin Hartinger, Andreas Seidl, Hansjoerg Toll, Johann Holzmann
Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
Gillian M. Keating